Xiaogang Li

机构：Mayo Clinic, WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida · ORCID：0000-0001-8135-342X

发表论文 209 篇 · 总被引 7801 次 · h-index 42

代表论文

• GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition (2024 · Advanced Science · 被引 39)
• GLP ‐ 1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and Ketosis (2025 · The FASEB Journal · 被引 11)
• Cellular senescence and its association with aldose reductase promote cyst growth in autosomal dominant polycystic kidney disease (2025 · Kidney International · 被引 10)
• P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism (2025 · Cell Death Discovery · 被引 9)
• In vivo base editing rescues ADPKD in a humanized mouse model (2025 · Nature Communications · 被引 6)
• Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging (2025 · The FASEB Journal · 被引 6)